Increased visfatin and leptin in pregnancies complicated by pre-eclampsia

References

• Sankaralingam S, Arenas I A, Lalu M M, Davidge S T. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 2006; 8: 1–20
   PubMedGoogle Scholar
• Rodie V A, Freeman D J, Sattar N, Greer I A. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?. Atherosclerosis 2004; 175: 189–202
   PubMed Web of Science ®Google Scholar
• van Beck E, Peeters L L. Pathogenesis of preeclampsia: a comprehensive model. Obstet Gynecol Surv 1998; 53: 233–239
   PubMedGoogle Scholar
• Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R. Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am J Hypertens 2008; 21: 582–586
   PubMed Web of Science ®Google Scholar
• Zavalza-Gomez A B, Anaya-Prado R, Rincon-Sanchez A R, Mora-Martinez J M. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract 2008; 80: 8–15
   PubMed Web of Science ®Google Scholar
• Zhong M, Tan H W, Gong H P, Wang S F, Zhang Y, Zhang W. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clin Endocrinol 2008; 69: 878–884
   PubMed Web of Science ®Google Scholar
• Chudek J, Wiecek A. Adipose tissue, inflammation and endothelial dysfunction. Pharmacol Rep 2006; 58: 81–88
   PubMedGoogle Scholar
• Kafulafula G E, Moodley J, Ojwang P J, Kagoro H. Leptin and pre-eclampsia in black African parturients. BJOG 2002; 109: 1256–1261
   PubMed Web of Science ®Google Scholar
• Redman C W, Sacks G P, Sargent I L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499–506
   PubMed Web of Science ®Google Scholar
• Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426–430
   PubMed Web of Science ®Google Scholar
• Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 2007; 56: 451–458
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R. Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol 2008; 69: 69–73
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Briana D D, Boutsikou M, Kouskouni E, Hassiakos D, Gourgiotis D. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007; 119: 1314–1318
   PubMed Web of Science ®Google Scholar
• Hu W, Wang Z, Wang H, Huang H, Dong M. Serum visfatin levels in late pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 2008; 87: 413–418
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77: 67–75
   PubMed Web of Science ®Google Scholar
• Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides K H. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000; 96: 559–564
   PubMed Web of Science ®Google Scholar
• Arduini D, Rizzo G. Normal values of Pulsatility Index from fetal vessels: a cross-sectional study on 1556 healthy fetuses. J Perinat Med 1990; 18: 165–172
   PubMed Web of Science ®Google Scholar
• Brar H S, Platt L D. Reverse end-diastolic flow velocity on umbilical artery velocimetry in high-risk pregnancies: an ominous finding with adverse pregnancy outcome. Am J Obstet Gynecol 1988; 159: 559–561
   PubMed Web of Science ®Google Scholar
• Vitoratos N, Chrystodoulacos G, Kouskouni E, Salamalekis E, Creatsas G. Alterations of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol 2001; 96: 59–62
   PubMed Web of Science ®Google Scholar
• Mise H, Yura S, Itoh H, Nuamah M A, Takemura M, Sagawa N, Fujii S. The relationship between maternal plasma leptin levels and fetal growth restriction. Endocr J 2007; 54: 945–951
   PubMed Web of Science ®Google Scholar
• Ozkan S, Erel C T, Madazli R, Aydinli K. Serum leptin levels in hypertensive disorder of pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 120: 158–163
   PubMed Web of Science ®Google Scholar
• Martinez-Abundis E, Gonzalez-Ortiz M, Pascoe-Gonzalez S. Serum leptin levels and the severity of preeclampsia. Arch Gynecol Obstet 2000; 264: 71–73
   PubMed Web of Science ®Google Scholar
• Seely E W, Solomon C G. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003; 88: 2393–2398
   PubMed Web of Science ®Google Scholar
• Kolaczynski J W, Nyce M R, Considine R V, Boden G, Nolan J J, Henry R, Mudaliar S R, Olefsky J, Caro J F. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 1996; 45: 699–701
   PubMed Web of Science ®Google Scholar
• Laivuori H, Kaaja R, Koistinen H, Karonen S L, Andersson S, Koivisto V, Ylikorkala O. Leptin during and after pre-eclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism 2000; 49: 259–263
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Briana D D, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D. Blood visfatin concentrations in normal full-term pregnancies. Acta Paediatr 2007; 96: 526–529
   PubMed Web of Science ®Google Scholar
• Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, Schernthaner G. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci 2006; 110: 605–609
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol 2007; 66: 434–439
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785–799
   PubMed Web of Science ®Google Scholar